Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
Journal
Oncologist
Journal Volume
22
Journal Issue
9
Pages
1075-1083
Date Issued
2017
SDGs
Publisher
AlphaMed Press
Type
journal article
